Accelerated Approval of Cancer Drugs-Righting the Ship of the US Food and Drug Administration

JAMA Intern Med. 2019 Jul 1;179(7):922-923. doi: 10.1001/jamainternmed.2019.0584.

Authors

Sarah S P DiMagno¹, Aaron Glickman¹, Ezekiel J Emanuel^{1

2}

Affiliations

¹ Department of Medical Ethics and Health Policy, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
² Department of Health Care Management, The Wharton School, University of Pennsylvania, Philadelphia.

PMID: 31135826
DOI: 10.1001/jamainternmed.2019.0584

No abstract available

Publication types

Comment

MeSH terms

Antineoplastic Agents*
Drug Approval*
United States
United States Food and Drug Administration

Substances

Antineoplastic Agents